To show the role of downstream complement components such as C5 or C5a-C5aR axis in CIA, administration of anti-C5 inhibitory (BB5.1) antibody was used and was found to both prevent the initiation and decrease the severity of arthritis (219, 241). This evidence concerns the gene C5AR1 and arthritic joint disease.